Intellectual Property Rights in Pharmaceutical Sector: Driving Innovation, Protection, And Economic Growth

Intellectual Property Rights (IPRs) constitute a cornerstone of modern innovation systems by providing legal protection to creations of the human intellect, including inventions, literary and artistic works, confidential knowledge, and industrial innovations. These rights grant time-bound exclusivity to creators and inventors, thereby safeguarding investments, promoting recognition, and fostering economic returns. This review critically examines the significance, categories, and historical development of IPRs, with particular emphasis on their role within the pharmaceutical sector. Various forms of intellectual property patents, copyrights, trademarks, trade secrets, geographical indications, and industrial designs are analyzed in terms of their contribution to innovation, industrial competitiveness, and global trade. The Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement, established under the World Trade Organization, is discussed as a landmark framework that harmonized international standards, particularly with respect to patent duration and enforcement. The review also outlines the patent filing process and the statutory duration of IPR protections across different categories. Within pharmaceuticals, patents, data exclusivity, and trade secrets emerge as pivotal instruments for protecting research investments, enabling commercialization, and ensuring therapeutic reliability. It is concluded that robust IPR frameworks not only stimulate innovation and public–private collaboration but also enhance global competitiveness and contribute significantly to sustainable economic and healthcare development.